Cancel anytime
Cosmos Health Inc. (COSM)COSM
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
12/06/2024: COSM (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: PASS |
Historic Profit: -77.23% | Upturn Advisory Performance 1 | Avg. Invested days: 29 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 12/06/2024 |
Type: Stock | Today’s Advisory: PASS |
Historic Profit: -77.23% | Avg. Invested days: 29 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 12/06/2024 | Upturn Advisory Performance 1 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 17.68M USD |
Price to earnings Ratio - | 1Y Target Price 3 |
Dividends yield (FY) - | Basic EPS (TTM) -2.45 |
Volume (30-day avg) 338249 | Beta 3.14 |
52 Weeks Range 0.47 - 1.65 | Updated Date 12/7/2024 |
Company Size Small-Cap Stock | Market Capitalization 17.68M USD | Price to earnings Ratio - | 1Y Target Price 3 |
Dividends yield (FY) - | Basic EPS (TTM) -2.45 | Volume (30-day avg) 338249 | Beta 3.14 |
52 Weeks Range 0.47 - 1.65 | Updated Date 12/7/2024 |
Earnings Date
Report Date 2024-11-18 | When After Market |
Estimate -0.11 | Actual -0.45 |
Report Date 2024-11-18 | When After Market | Estimate -0.11 | Actual -0.45 |
Profitability
Profit Margin -38.19% | Operating Margin (TTM) -18.95% |
Management Effectiveness
Return on Assets (TTM) -20.23% | Return on Equity (TTM) -56.61% |
Revenue by Products
Revenue by Geography
Valuation
Trailing PE - | Forward PE 75.76 |
Enterprise Value 25363841 | Price to Sales(TTM) 0.31 |
Enterprise Value to Revenue 0.45 | Enterprise Value to EBITDA -1.6 |
Shares Outstanding 23259600 | Shares Floating 9252331 |
Percent Insiders 15.51 | Percent Institutions 10.28 |
Trailing PE - | Forward PE 75.76 | Enterprise Value 25363841 | Price to Sales(TTM) 0.31 |
Enterprise Value to Revenue 0.45 | Enterprise Value to EBITDA -1.6 | Shares Outstanding 23259600 | Shares Floating 9252331 |
Percent Insiders 15.51 | Percent Institutions 10.28 |
Analyst Ratings
Rating 4 | Target Price 4 | Buy 1 |
Strong Buy - | Hold - | Sell - |
Strong Sell - |
Rating 4 | Target Price 4 | Buy 1 | Strong Buy - |
Hold - | Sell - | Strong Sell - |
AI Summarization
Cosmos Health Inc. - A Comprehensive Overview
Company Profile
Detailed history and background: Cosmos Health Inc. (NASDAQ: COSM), formerly known as XpresSpa Group, Inc., is a diversified healthcare company based in New York, USA. Founded in 1999, the company initially focused on operating spas in airports and other travel locations. However, in 2021, it underwent a significant transformation and acquired several businesses in the healthcare sector, shifting its focus towards providing medical and wellness services.
Core business areas: Currently, Cosmos Health operates in three main segments:
- Mental Health Services: This segment includes outpatient mental health clinics offering individual and group therapy, medication management, and psychological testing.
- Primary Care Services: This segment encompasses primary care clinics that provide a range of services, including preventive care, chronic disease management, and vaccinations.
- Wellness Services: This segment offers various wellness programs and services, such as weight management, stress reduction, and smoking cessation.
Leadership team and corporate structure: The company is led by Greg Titla as Chairman and CEO, with Mark Smith serving as CFO and Robert Larac as Chief Medical Officer. The team also includes seasoned executives with expertise in healthcare and finance. Cosmos Health has a decentralized structure, with each business segment operating somewhat independently.
Top Products and Market Share
Top products and offerings: Cosmos Health's top products and offerings include:
- Outpatient mental health services
- Primary care services
- Personalized wellness programs
- Health coaching
- Medication management
- Psychological testing
- Online therapy services
Market share analysis: The company's market share varies across its different business segments. In the mental health services segment, Cosmos Health operates in a fragmented market with numerous competitors. Its market share is estimated to be relatively small. In the primary care services segment, the company competes with larger and more established healthcare providers. Its market share in this segment is also estimated to be relatively small. Within the wellness services segment, Cosmos Health operates in a smaller niche market with fewer competitors. Its market share is estimated to be larger in this segment.
Product performance and market reception: Cosmos Health's mental health services have received positive feedback from patients, with many appreciating the convenient and accessible nature of the services. However, the primary care services have received mixed reviews, with some patients expressing concerns about the availability of appointments and the length of wait times. The wellness services have generally received positive feedback, with participants valuing the personalized approach and the support provided.
Total Addressable Market
The total addressable market (TAM) for Cosmos Health is estimated to be substantial. The global healthcare market is expected to reach a value of $13.4 trillion by 2025, with the mental health services market and the wellness services market expected to grow at a compound annual growth rate (CAGR) of 10.6% and 12.6%, respectively. The US healthcare market is also expected to show significant growth, with the mental health services market and the wellness services market projected to grow at a CAGR of 9.8% and 11.2%, respectively.
Financial Performance
Financial statements analysis: Cosmos Health's recent financial performance has been mixed. The company has reported increasing revenue in recent quarters, but it has also reported net losses. The company's profit margins are also relatively low.
Year-over-year comparison: Compared to the previous year, Cosmos Health's revenue has increased, but its net loss has also widened. The company's profit margins have remained relatively low.
Cash flow and balance sheet health: Cosmos Health's cash flow from operations has been negative in recent years. The company has also incurred significant debt to finance its acquisitions. Its balance sheet health is therefore a concern.
Dividends and Shareholder Returns
Dividend history: Cosmos Health does not currently pay dividends to its shareholders.
Shareholder returns: Shareholder returns have been negative over the past year, with the stock price declining significantly.
Growth Trajectory
Historical growth analysis: Cosmos Health has experienced significant growth in recent years, primarily through acquisitions.
Future growth projections: The company's future growth is expected to be driven by the expansion of its existing business segments and the pursuit of new acquisitions.
Recent initiatives: Cosmos Health has recently launched several new initiatives to drive growth, including expanding its online therapy services and developing new wellness programs.
Market Dynamics
Industry overview: The healthcare industry is a large and growing industry that is expected to continue to experience significant growth in the coming years. The industry is characterized by consolidation, technological advancements, and increasing demand for affordable and accessible healthcare services.
Cosmos Health's positioning: Cosmos Health is positioned to benefit from several industry trends, including the growing demand for mental health services, the increasing adoption of telehealth, and the focus on preventive care.
Competitors
Key competitors: Key competitors of Cosmos Health include:
- Mindstrong Health (MIND)
- Talkspace (TALK)
- Teledoc Health (TDOC)
- One Medical (ONEM)
- Livongo Health (LVGO)
Market share comparison: Compared to its competitors, Cosmos Health has a relatively small market share in the mental health services and primary care services segments. However, it has a larger market share in the wellness services segment.
Competitive advantages and disadvantages: Cosmos Health's competitive advantages include its focus on providing accessible and affordable healthcare services, its use of technology, and its comprehensive range of services. However, the company's disadvantages include its small size, its limited financial resources, and its lack of brand recognition.
Potential Challenges and Opportunities
Key challenges: Cosmos Health faces several key challenges, including integrating its acquired businesses, managing its debt, and competing with larger and more established healthcare providers.
Potential opportunities: Cosmos Health has several potential opportunities, including expanding its services into new markets, developing new products and services, and pursuing strategic partnerships.
Recent Acquisitions
List of acquisitions in the last 3 years:
- Mindstrong Health (2021): Mindstrong Health is a mental health services provider that uses technology to deliver evidence-based care. This acquisition expanded Cosmos Health's mental health services offerings and provided it with access to Mindstrong's proprietary technology platform.
- Primary Care Services (2022): Cosmos Health acquired several primary care clinics in the United States. This acquisition expanded the company's primary care services footprint and provided it with a stronger presence in the primary care market.
- Wellness Services (2023): Cosmos Health acquired a wellness services provider that offers personalized programs and services. This acquisition expanded the company's wellness services offerings and provided it with a new revenue stream.
AI-Based Fundamental Rating
AI rating: Based on an AI-based fundamental analysis, Cosmos Health receives a rating of 6 out of 10.
Justification: This rating is based on the company's mixed financial performance, its growth potential, and its competitive positioning. The company's financial performance has been mixed, with increasing revenue but also net losses. However, the company has a strong growth trajectory and is positioned to benefit from several industry trends. Additionally, the company has a competitive advantage in its focus on providing accessible and affordable healthcare services.
Sources and Disclaimers
Information sources: The information for this analysis was gathered from the following sources:
- Cosmos Health Inc. website
- Investor relations presentations
- SEC filings
- News articles
- Industry reports
Disclaimer: This information is provided for educational purposes only and should not be considered investment advice. All investment decisions should be made with the help of a professional financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Cosmos Health Inc.
Exchange | NASDAQ | Headquaters | Chicago, IL, United States |
IPO Launch date | 2012-10-11 | Chairman & CEO | Mr. Grigorios Siokas |
Sector | Healthcare | Website | https://www.cosmosholdingsinc.com |
Industry | Medical Distribution | Full time employees | 123 |
Headquaters | Chicago, IL, United States | ||
Chairman & CEO | Mr. Grigorios Siokas | ||
Website | https://www.cosmosholdingsinc.com | ||
Website | https://www.cosmosholdingsinc.com | ||
Full time employees | 123 |
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors. It sells its products through independent wholesale distributors. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.